Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 10/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2227926 | 1.00 | MAOB (0.59) | MAOBCYP3A4TP53MAOATSHR | |
| SCHEMBL13338101 | 0.86 | MAOB (0.59) | MAOBMAOATSHRALDH1A1ACHE | |
| SCHEMBL28890994 | 0.84 | MAOB (0.48) | MAOBCYP3A4TP53MAOATSHR | |
| SCHEMBL31691312 | 0.81 | ALDH1A1 (0.65) | MAOBCYP3A4MAOATSHRALDH1A1 | |
| SCHEMBL20530603 | 0.81 | MAOB (0.58) | MAOBCYP3A4MAOAACHECA12 | |
| SCHEMBL3054840 | 0.81 | CYP3A4 (0.58) | MAOBCYP3A4TP53MAOATSHR | |
| SCHEMBL30085021 | 0.81 | CYP3A4 (0.58) | MAOBCYP3A4TP53MAOATSHR | |
| SCHEMBL513677 | 0.81 | CYP3A4 (0.58) | MAOBCYP3A4TP53MAOATSHR | |
| SCHEMBL30772215 | 0.79 | CYP3A4 (0.61) | MAOBCYP3A4TP53TSHRAPP | |
| SCHEMBL20530611 | 0.79 | MAOB (0.54) | MAOBCYP3A4MAOAALDH1A1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388523-A1 | 18F-LABELED PEPTIDE LIGANDS USEFUL IN PET AND CERENKOV LUMINESCENE IMAGING | CORNELL UNIVERSITY (US) | 2025-12-25 | — | — | US | disclosed |
| CN-115716808-A | 18F-labeled triazoles containing PSMA inhibitors | 康奈尔大学 | 2023-02-28 | — | — | CN | disclosed |
| CN-109843338-B | Containing PSMA inhibitors 18 F-labelled triazoles | 康奈尔大学 | 2022-12-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388523-A1 | 18F-LABELED PEPTIDE LIGANDS USEFUL IN PET AND CERENKOV LUMINESCENE IMAGING | SCTR, SSTR3, SSTR1 | MAOB 3159/4885CYP3A4 4388/4885TP53 3813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.